Redefining Framingham. Framingham risk scores have been widely used to assess cardiovascular risk for decades. Yes in 2009 a study showed more than 75 percent of patients hospitalized for heart attacks had cholesterol levels that would indicate they were not high risk for a cardiovascular event.
What are we missing?
- In 2010, the ARIC study demonstrated that C-IMT radically re-defines
- Framingham Risk in eye-opening ways.
- The results were dramatic:
- 23% of patients were reclassified when C-IMT and
- plaque information were added to Framingham Risk.
Let’s take a look at how adding C-IMT and Carotid
Plaque to standard risk scores can change treatment strategies:
Conclusion: C-IMT Better Defines Risk.